1 / 5

Aim

VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts.

cherylej
Download Presentation

Aim

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts William J. Culpepper, PhD, MA; Mitchell T. Wallin, MD; Laurence S. Magder, PhD, MPH; Eli Perencevich, MD, MS; Walter Royal, MD; Douglas D. Bradham, DrPH, MA, MPH; Gary Cutter, PhD; Christopher T. Bever, MD

  2. Aim • Create VHA MS Surveillance Registry (MSSR) and provide detailed description of epidemiologic and clinical composition of modern VHA MS population. • Provide an updated description of epidemiologic and clinical characteristics of MS in U.S. by contrasting MSSR with other published MS cohorts. • Relevance • Large, longitudinal, and diverse cohort is needed to understand risk factors for development/progression of MS.

  3. Methods • Cross-sectional, mail-based survey of stratified, random sample of 3,905 VHA users with MS. • Detailed demographic and clinical data as well as patient-reported outcomes assessing disability/QoL were collected —1,379 Veterans were enrolled into MSSR. • MS Comparison Cohorts • New York MS Consortium (NYMSC) • Sonya Slifka Longitudinal Multiple Sclerosis Study (SLIFKA) • North American Research Consortium on MS (NARCOMS)

  4. Results • Respondents did not differ from non-respondents with regard to demographics or region. • Age of MS onset and diagnosis, subtype distribution, and the most prevalent MS symptoms were very similar across cohorts. • MSSR appears to be representative of general MS population.

  5. Conclusion • Investigators should review data collection methods and sampling strategies of each cohort carefully with respect to their research question(s) when deciding which cohort(s) to use. • While some demographic differences were observed between cohorts, clinical composition of the MSSR was very similar to other MS cohorts. • MSSR is generally representative of larger U.S. MS population. • Detailed healthcare utilization and cost data maintained by VHA combined with data from MSSR provides a unique and demographically diverse MS cohort for future study.

More Related